The pathogenicity of SARS-CoV-2 in hACE2 transgenic miceLinlin Bao, Chuan Qin, Jiangning Liu et al.|Nature|2020Cited by 1.2k
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2Hui Wang, Xiaoming Yang, Yuntao Zhang et al.|Cell|2020Cited by 802